ÂÜÀòÂÒÂ×

Jacki Fontaine has extensive experience in clinical operations, with over 24 years of work experience in the pharmaceutical industry. Jacki currently serves as the Executive Director of Clinical Operations at QED Therapeutics, a position they have held since January 2022. Prior to their current role, they worked as the Senior Director of Clinical Operations at QED Therapeutics from January 2020 to January 2022, and as the Director of Clinical Operations from April 2018 to January 2020.

Before joining QED Therapeutics, Jacki worked at OncoMed Pharmaceuticals as the Director of Clinical Operations from January 2018 to April 2018, and as the Associate Director of Clinical Operations from September 2013 to December 2017.

Jacki also gained experience at XenoPort, where they served as the Associate Director of Clinical Operations from January 2013 to August 2013, and as the Clinical Trials Manager from November 2007 to January 2013.

Jacki's early career includes working at Pharmacyclics as the Clinical Program Manager from September 1999 to November 2007, and at Quintiles as a Clinical Research Associate from September 1997 to September 1999.

Overall, Jacki Fontaine has held various leadership positions in clinical operations throughout their career, demonstrating expertise in managing clinical trials and programs.

Jacki Fontaine attended UC Santa Barbara, where they pursued a Bachelor of Science (B.S.) degree in Biology/Biological Sciences. However, no specific information about the start or end year of their education at this institution is provided.